2,6,9-trisubstituted purines
TW202629563APending Publication Date: 2026-07-16ASTRAZENECA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115111745
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-12-16
- Filing Date
- 2023-12-15
- Publication Date
- 2026-07-16
Abstract
Compounds having the structure of Formula (I): , and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are as defined in the specification; pharmaceutical compositions comprising such compounds and salts; use of such compounds and salts to treat or prevent cyclin-dependent kinase 2 (CDK2)-mediated conditions; kits comprising such compounds and salts; and methods for manufacturing such compounds and salts.
Need to check novelty before this filing date? Find Prior Art